Analyst Ratings for Damora Therapeutics (DMRA)
DMRA Rating Summary
DMRA Price Target Summary
- Highest: $55.00 (Leerink)
- Lowest: $35.00 (Wedbush)
- Average: $44.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$44.20 (+74.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | H.C. Wainwright | Mitchell Kapoor | New Coverage | Buy (N/A) |
45.00 (N/A) |
20.15 (25.36) |
25.86% | Details |
| 6/8/2026 | TD Cowen | Marc Frahm | New Coverage | Buy (N/A) |
N/A (N/A) |
21.01 (25.36) |
20.7% | Details |
 |
||||||||
|
||||||||
|
||||||||
